Express | Key Phase 3 clinical results of the new hepatitis B vaccine published, stimulating antibody levels 5-8 times the approved vaccine
Time of Update: 2021-05-21
▎Editor of WuXi AppTec's content team On May 12, 2021, VBI Vaccines (hereinafter referred to as VBI) announced that the key phase 3 clinical trial data of its preventive 3-antigen hepatitis B virus (HBV) vaccine candidate in adults is in The Lancet Infectious Published on Diseases.
The second wave of the new crown outbreak is coming! Emergency withdrawal after CDC releases new anti-epidemic guidelines
Time of Update: 2020-10-06
china's current anti-epidemic strategy is proactive defense strategy, while other countries have difficulty controlling the outbreak, can only wait for the vaccine, but the vaccine will take time.
Anti-vaccine technology moved out The German government plans to invest 2.4 billion yuan in new crown vaccine developer VacCure
Time of Update: 2020-07-08
, the German government plans to invest 300 million euros (about 2.4 billion yuan) in VacCure, a new coronavirus vaccine developer, to acquire a 23 percent stake in the company, foreign media reporte
Tetravalent HPV recombinant cervical cancer vaccine reduces infection and lesions in women under 45 years of age
Time of Update: 2020-07-07
, the latest data revealed at the 24th International Conference on Papillomavirus (IPC) in Beijing showed that in women aged 24 to 45, the quadrouted human papillomavirus (6, 11, 16) developed by Me